Objective: To highlight differences in the quanti®cation of transferrin receptor (TfR) concentration (a reliable index of iron de®ciency) between three different assay methods.
Introduction
Iron de®ciency anemia is the most prevalent nutritionrelated health problem in the world (Scrimshaw, 1991) . It is identi®ed with a combination measurement of hemoglobin plus at least one of ferritin, free erythrocyte protoporphyrin, serum iron, transferrin, or iron-binding capacity (Life Science Research Of®ce, 1984) . Individuals at risk of iron de®ciency anemia have low serum ferritin concentrations (corresponding to low stores of iron) and low serum transferrin concentrations (corresponding to minimal availability of iron to the erythrocyte).
Both ferritin and transferrin measurements suffer from a lack of speci®city and sensitivity (Lipschitz et al, 1974; Dallman & Reeves, 1984; Borel et al, 1991; Ahluwalia et al, 1993; Baynes, 1996; Cooper & Zlotkin, 1996) . A new indicator of iron status, the circulating soluble transferrin receptor (TfR), provides the only accurate assessment of functional iron de®ciency, which occurs between the initial depletion of storage iron and the overt development of anemia Skikne et al, 1990; Ahluwalia et al, 1993; Cook et al, 1993; Cooper & Zlotkin, 1996; Anttila & Cook, 1997; Punnonen & Irjala, 1997) .
Soluble TfR is released from cells into the vascular compartment in direct proportion to the number of cellular receptors expressed (Kohgo et al, 1986; Flowers et al, 1989) . Serum TfR always circulates bound to ligand. The serum receptor is an 85 kDa truncated extracellular domain of the cell-surface receptor, produced through proteolytic cleavage by a serine protease, predominantly at the surface of the exosome within the multivesicular body (Shih et al, 1990; Baynes, 1996) . Unlike other methods of assessing iron availability to the developing erythrocyte, increases in TfR concentration are speci®c to iron de®ciency (Ferguson et al, 1992; Punnonen et al, 1994) .
Several enzyme-linked immunoassay (EIA) systems have been developed to measure TfR, but each system reports a different normal range (see Table 1 ). In healthy adults, the Ramco assay reports a normal TfR range of 2.9± 8.3 mg/l; the Quantikine assay reports 0.85±3.05 mg/l. An indirect enzyme-linked immunosorbent assay (ELISA) developed in our laboratory (`Lab') provides a TfR range of 2.4±8.0 mg/l in healthy infants (Yeung & Zlotkin, 1997) .
The differences in the reported normal ranges appear to be greater than those that would be expected from intraand inter-assay variability and/or differences in sensitivity (limit of detection) between the three methods. Despite the differences in the reported normal ranges, absolute TfR concentrations derived from different assay methods have been directly compared in the literature, which leads to confused interpretation (Nielsen et al, 1994) . Thus, the objective of our study was to examine the limitations of comparison of assay results by measuring and reporting on the differences in TfR concentration between three assay methods on the same reference serum samples.
Materials and methods
Two commercially available TfR kits were used in the study, both EIAs: the Ramco Human TfR Assay Kit (Ramco Laboratories Inc., Houston, TX, USA) and the Quantikine Human TfR Immunoassay (R & D Systems, Minneapolis, MN, USA). Two reference sera supplied in the Ramco kit were used throughout the study for all assays: one reported by Ramco to be in the normal range (4.3±7.7 mg/l) and the other to be elevated (9.1±15.9 mg/l) for TfR.
Between 18 and 24 replicates of the`normal' and elevated' reference sera were assayed with each of the Ramco, Quantikine and Lab assays. Student's t-test was used to compare normal vs elevated samples within each assay method.
Repeatability and measurement agreement within each of the assays was determined according to the method of Bland & Altman (1986) :
The standard deviation (s.d.) of differences for each assay was determined by one-way analysis of variance. All statistical analyses were performed using SAS software, version 6.12 (SAS Institute, Cary, NC, USA). P values 0.05 were considered signi®cant. The British Standards Institution (1979) has de®ned repeatability within an assay as acceptable if 95% of differences between individual replicates and the mean of all replicates are within two standard deviations ( AE 2 s.d.) of the mean. Bland & Altman (1986) de®ned limits of agreement between two methods (for example, the results from Ramco vs Quantikine assays) as the differences between the means of the two methods AE twice the corrected standard deviation of the differences. In simple terms, the limits of agreement describe the range by which one method over-or underestimates another. If this overor underestimation is clinically signi®cant, the methods do not agree and cannot be used interchangeably. In this study, we de®ned clinically signi®cant limits of agreement as over-or underestimation wide enough to cause misdiagnosis between normal iron status and iron de®ciency.
Results
TfR measurements for elevated and normal sera with each of these assay methods are shown in Table 1 . Mean TfR concentrations for the elevated reference serum samples were higher than the normal reference samples within each individual assay (P`0.001). The intra-assay coef®cient of variation for each assay for both elevated and normal samples is shown in Table 2 .
For both the Ramco and Lab assays, 95% of the differences between individual replicates and the mean of all replicates fell within 2 s.d. of the mean (that is, they were with the limits deemed acceptable by the British Standards Institution); for the Quantikine assays, 92% fell within 2 s.d. (Figure 1) 
Discussion
The intra-assay coef®cients of variation for the Ramco and Quantikine assays obtained during this study were higher than those reported by the manufacturer of the kits (Table  2) . This is likely due to the larger number of replicates used by the Ramco (n 60) and Quantikine (n 48) manufacturers. However, the repeatability coef®cients of both the Ramco and Lab assays were acceptable according to the British Standards Institution (1979) , whereas that of the Quantikine assay kit was not. Repeatability is important in method comparisons because high variation in repeated measurements on the same sample depresses agreement between the two methods.
Since differences between assays were all greater for the normal than for the elevated samples, it is likely that calculated limits of agreement are broader for higher TfR values and narrower for lower values. However, the overall disparity between assay methods makes comparisons of For healthy adults (commercial kits) or healthy infants (Lab kit). b All data for`elevated' sera differed signi®cantly from those for`normal' sera measured with the same kit (P`0.001). 
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TfR values derived from different methods unacceptable. For example, we recently reported (Yeung & Zlotkin, 1997 ) the mean TfR value for normal healthy infants 9± 15 months of age to be 4.4 mg/l, using our Lab assay. Values above 7 mg/l were above the 95th centile, considered to be indicative of iron de®ciency. Based on the upper limit of agreement, the Ramco assay could overestimate this mean of 4.4 mg/l by as much as 3.12 mg/l. Thus, a Ramco value of 7.52 mg/l would be incorrectly interpreted as a high value if compared directly to normative data based on our Lab assay. This would lead to misdiagnosing an infant who has a serum TfR concentration within the normal range as being clinically de®cient in iron.
The two methods therefore cannot be used interchangeably. The potential for such misinterpretation is far greater when comparing values derived from the two commercial assays, because of the wider limits of agreement between the Ramco and Quantikine assays.
The considerable overlap in the normal ranges reported for these three methods of TfR quanti®cation (Table 1) has already led to this kind of confusion in interpretation. Nielsen and associates (1994) directly compared results using the Quantikine method with literature values based on the Ramco kit. The authors noted an inverse correlation between serum ferritin and TfR concentrations, as might be expected in patients with exhausted iron stores; but they state that the elevations in TfR were only moderate (mean, 2.7 mg/l) compared to a similar study of patients with iron de®ciency anemia by Ferguson and colleagues (1992) . In Ferguson et al's study, however, TfR values were based on the Ramco assay, and consequently, were markedly higher (mean, 14 mg/l). In fact, a number of Nielsen et al's patients had dramatic elevations in TfR compared to Quantikine's reported normal ranges and the values obtained in our current study.
The publication of normative centile estimates for TfR in infants based on the Lab assay (Yeung & Zlotkin, 1997) has increased the likelihood that laboratory values for TfR will be misinterpreted. TfR concentrations above the published normal range may indicate iron de®ciency, but only when our Lab assay is used for the measurement. Values from other assay methods on the same sample might be higher or lower, creating a great potential for misinterpretation and misdiagnosis.
Despite the disparity in quanti®cation of TfR between methods, Ramco, Quantikine and Lab assays were all able to distinguish between elevated and normal serum samples. We have shown that the limits of agreement between each pair of assay methods are wide enough to cause misdiagnosis; thus, the methods cannot be used interchangeably. Recognition of the relative differences in the values obtained from each of the assays will have a major effect on the interpretation of TfR concentration as an index of iron de®ciency. This study highlights the urgent need for standardization of different assays to obtain uniform and comparable results. Assays for serum transferrin receptor GS Yeung
